恆潤股份(603985.SH):終止定增事項
格隆匯 11 月 10日丨恆潤股份(603985.SH)公佈,公司於2020年11月10日召開第四屆董事會第五次會議,審議通過了《關於公司終止非公開發行股票事項的議案》。
公司充分考慮當前市場與政策環境、結合自身實際情況及發展規劃等諸多因素,並與相關各方充分的溝通及審慎論證,認為當下開展募投項目的主客觀條件尚不成熟,需進一步夯實項目基礎,因此,出於維護公司全體股東,特別是中小股東利益的考慮,決定終止此次非公開發行A股股票事項。
公司已與此次非公開發行A股股票的發行對象承立新簽署《附生效條件的股份認購合同》,公司此次非公開發行股票事項終止之後,上述股份認購合同終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.